Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

Creative Commons License

ÇAVUŞOĞLU Y., Korkmaz S., DEMİRTAŞ S., Gencer E., Sasmaz H., MUTLU F., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.15, sa.8, ss.611-617, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 8
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5152/akd.2015.6156
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.611-617
  • Anahtar Kelimeler: ischemia modified albumin, heart failure, acute, PERCUTANEOUS CORONARY INTERVENTION, TRANSIENT MYOCARDIAL-ISCHEMIA, OXIDATIVE STRESS, COBALT BINDING, FAILING MYOCARDIUM, MARKER, ANGIOPLASTY, MECHANISMS, EFFICIENCY, DIAGNOSIS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatments on IMA levels.